Lenvatinib Impurities - SZEB

Lenvatinib is an anti-cancer medication for the treatment of certain kinds of thyroid cancer and for other cancers as well. Lenvatinib is approved (since 2015) for the treatment of differentiated thyroid cancer that is either locally recurrent or metastatic, progressive, and did not respond to treatment with radioactive iodine.

SZEB manufacture and furnish high quality Lenvatinib impurity for global markets. More information is available on the official website: https://www.ex-biotech.com. If you have any questions, please send an email to sale@ex-biotech.com. We are looking forward to cooperating with you.

The following are some of the impurities of Lenvatinib :